Treatments for Neonatal acute respiratory distress syndrome

FDA-approved drugs, patient assistance programs, and travel grants tracked on UniteRare for this condition.

ℹ

Treatment data is extracted from FDA drug labels, DailyMed, and openFDA through automated and AI-assisted pipelines that read both structured records and unstructured label text.

Report missing data

FDA-approved treatments (2)

Exosurf Neonatal for Intratracheal Suspension
Colfosceril palmitate, cetyl alcohol, tyloxapol
Glaxo Wellcome Inc.
Infasurf
calfactant
ONY Biotech Inc.
Approved Jul 1998

Patient support programs (2)

Copay cards, manufacturer assistance, and foundation grants. Verification status shown on each card.

Exosurf Neonatal for Intratracheal Suspension

Glaxo Wellcome Inc.

Exosurf Neonatal for Intratracheal Suspension — Contact Glaxo Wellcome Inc.

Unverified — confirm before calling

Patient Assistance

Manufacturer Program

Accepting applications

Infasurf

ONY Biotech Inc.

Infasurf — Contact ONY Biotech Inc.

Unverified — confirm before calling

Patient Assistance

Manufacturer Program

Accepting applications

More about Neonatal acute respiratory distress syndrome